Which treatment saves more lives from lung clots? major study launches
NCT ID NCT07603700
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 1,300 people with moderate-risk pulmonary embolism (blood clots in the lungs) to compare three treatments: blood thinners, clot-busting drugs, and mechanical clot removal. Researchers will track deaths, heart recovery, bleeding risks, and quality of life over 90 days. The goal is to find the safest and most effective approach for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••